Page contentsKey factsDecisionKey facts Active Substance Ibuprofenparacetamol Therapeutic area Pain Decision number P/0135/2018 PIP number EMEA-002002-PIP02-17 Pharmaceutical form(s) Oral suspension Condition(s) / indication(s) Treatment of febrile disordersTreatment of pain Route(s) of administration Oral use Contact for public enquiries Farmalider, S.AE-mail: carloscalandria@farmalider.comTel. +34 9166 12335 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 07/05/2018DecisionP/0135/2018: EMA decision of 7 May 2018 on the granting of a product-specific waiver for ibuprofen / paracetamol (EMEA-002002-PIP02-17)AdoptedReference Number: EMA/258445/2018 English (EN) (64.32 KB - PDF)First published: 27/11/2018ViewShare this page